TeraWulf Shares Gain After Securing Over 1GW Hyperscale Data Campus in Kentucky Singapores Young Professionals Earn High Incomes but Struggle with Financial Insecurity Amid Rising Living Standards Delivery Hero Shares Surge 10 as Uber Reportedly Revives Takeover Interest Indonesian Commodity Exporters Raise Concerns Over Governments State Monopoly Plan Kevin Warshs Potential Fed Regime Change Targets Wall Streets Operational Plumbing Spencer Pratts Social Media Strategy Could Reshape Political Campaigning But Can It Win LA Mayoral Race TRNO Q1 2026 Earnings Massive EPS Beat as Earnings Surge 99 Above Estimates Alaunos Therapeutics TCRT Q4 2023 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline ACRS Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Natuzzi SpA NTZ Q4 2011 Earnings EPS Falls Short as Restructuring Weighs on Results AVAL Q2 2025 Earnings Strong EPS Amidst Mixed Market Signals CXDO Q1 2026 Earnings EPS Surprises 256 Above Estimates Capital Bancorp Inc CBNK Holds Steady Near Support as Modest Decline Suggests Consolidation Siebert Financial Corp SIEB Surges 319 as Bullish Momentum Builds Near Key Resistance SKYX Platforms Corp SKYX Slides 225 as Shares Approach Critical Support Level Cyngn Inc CYN Slips 148 as Shares Test Near Support Zone CGI Inc GIB Edges Higher as IT Services Sector Shows Steady Momentum Dhoot Transmission Files Updated DRHP for 1400 Crore IPO with Sebi FCX Q1 2026 Earnings Strong Earnings Beat Amid Robust Copper Demand Voya Financial VOYA Slips 176 as Stock Tests Key Support Levels PGIM High Yield Bond Fund ISD Holds Steady at 1299 as Income Investors Seek Stability Paysafe PSFE Shows Resilience Uptrend Challenges Key Resistance at 818 American States Water AWR Edges Higher Amid Steady Utility Demand American Battery Technology Company ABAT Surges 6 as Support Holds Key Levels to Watch BioLife Solutions BLFS Faces Headwinds Shares Decline 319 to 2395 Amylyx Pharmaceuticals AMLX Sees Uptick Amid Key Resistance Test Biotech Stock Gains 285 Bolt Biotherapeutics BOLT Slips 12 as Shares Test Key Support at 465